AMMONIUM TETRACHLOROZINCATE

Details

Stereochemistry	ACHIRAL
Molecular Formula	4Cl.Zn.2H4N
Molecular Weight	243.298
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of AMMONIUM TETRACHLOROZINCATE

SMILES

[NH4+].[NH4+].[Cl-].[Cl-].[Cl-].[Cl-].[Zn++]

InChI

InChIKey=QOQUXKCHSZSKOT-UHFFFAOYSA-L

InChI=1S/4ClH.2H3N.Zn/h4*1H;2*1H3;/q;;;;;;+2/p-2

HIDE SMILES / InChI

Molecular Formula	ClH
Molecular Weight	36.461
Charge	0
Count	MOL RATIO 4 MOL RATIO (average)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	H3N
Molecular Weight	17.0305
Charge	0
Count	MOL RATIO 2 MOL RATIO (average)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	Zn
Molecular Weight	65.409
Charge	2
Count	MOL RATIO 1 MOL RATIO (average)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Streptococcus mutans 41	Inhibitor 8,504
respiratory burst 39	Activator 1,447
transformed cell apoptotic process 104	Activator 1,447
Methotrexate 38	Hydrolytic Enzyme 38
ultraviolet B-induced damage 38	Interacts 323
T cell mediated immunity 40	Activator 1,447
Zinc transporter ZIP1 38	Binding Agent 1,076
Zinc transporter ZIP2 38	Binding Agent 1,076

Conditions

Condition	Modality	Highest Phase	Product
Unknown 2,596
Unknown 2,596
Unknown 2,596
Caries 43	Preventing	Basic research	Unknown
Ulcerative colitis 125	Primary	Approved 8,583	CORTROPHIN-ZINC
Zinc deficiency 39	Primary	Preclinical	Unknown
Acute myeloid leukemia 141	Primary	Basic research	Unknown
Breast cancer 432	Primary	Basic research	Unknown
Renal insufficiency 40	Secondary	Approved 8,583	VORAXAZE
Diaper dermatitis 38	Primary	Approved 8,583	VUSION
Poison Ivy dermatitis 38	Primary	Approved 8,583	ZINC OXIDE
Gastrointestinal disorders 94	Primary	Approved 8,583	ZINC SULFATE
Mucositis 39	Primary	Phase III 665	ZINC SULFATE
Dysgeusia 38	Primary	Phase III 665	ZINC SULFATE
Unknown 2,596

PubMed

Show entries

Title	Date	PubMed
In vitro activity of zinc salts against human rhinoviruses.	1987 Apr	3038000
A medicated polycarboxylate cement to prevent complications in composite resin therapy.	1990 Jan	2404104
Zinc inhibition of renin and the protease from human immunodeficiency virus type 1.	1991 Sep 10	1888732
Combined effects of argon laser irradiation and fluoride treatments in prevention of caries-like lesion formation in enamel: an in vitro study.	1999 Spring	10686872
Bioavailability, biodistribution, and toxicity of BioZn-AAS(1): a new zinc source. comparative studies in rats.	2000 Sep	10978858

Showing 1 to 5 of 50 entries

Previous1 2 3 4 5…10Next

Sample Use Guides

In Vivo Use Guide

single intravenous injection of 50 Units per kg

Route of Administration: Intravenous

In Vitro Use Guide

Unknown

Substance Class	Chemical
Record UNII	NK9T00M5VV
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

AMMONIUM CHLOROZINCATE ((NH4)2(ZNCL4))

Preferred Name

English

AMMONIUM TETRACHLOROZINCATE

Common Name

English

AMMONIUM TETRACHLOROZINCATE [MI]

Common Name

English

ZINC CHLORIDE-AMMONIUM CHLORIDE COMPLEX (1:2)

Common Name

English

ZINCATE(2-), TETRACHLORO-, DIAMMONIUM

Common Name

English

Showing 1 to 5 of 11 entries

Previous1 2 3Next

Show entries

Code System

Code

Type

Description

CAS

14639-97-5

PRIMARY

PUBCHEM

61754

PRIMARY

MERCK INDEX

m1826

PRIMARY

Merck Index

ECHA (EC/EINECS)

238-687-6

PRIMARY

FDA UNII

NK9T00M5VV

PRIMARY

Showing 1 to 5 of 7 entries

Previous1 2Next

SMILES

InChI

CNS Activity

Originator

Approval Year

Targets

Conditions

PubMed

Patents

Sample Use Guides